TY - UNPB
T1 - New implementation of data standards for AI research in precision oncology. Experience from EuCanImage
AU - Garcia-Lezana, Teresa
AU - Bobowicz, Maciej
AU - Frid, Santiago
AU - Rutherford, Michael
AU - Recuero, Mikel
AU - Riklund, Katrine
AU - Cabrelles, Aldar
AU - Rygusik, Marlena
AU - Fromont, Lauren
AU - Francischello, Roberto
AU - Neri, Emanuele
AU - Capella, Salvador
AU - Prior, Fred
AU - Bona, Jonathan
AU - Nicolas, Pilar
AU - Starmans, Martijn P. A.
AU - Lekadir, Karim
AU - Rambla, Jordi
AU - Consortium, EuCanImage
PY - 2024
Y1 - 2024
N2 - An unprecedented amount of personal health data, with the potential to revolutionise precision medicine, is generated at healthcare institutions worldwide. The exploitation of such data using artificial intelligence relies on the ability to combine heterogeneous, multicentric, multimodal and multiparametric data, as well as thoughtful representation of knowledge and data availability. Despite these possibilities, significant methodological challenges and ethico-legal constraints still impede the real-world implementation of data models. The EuCanImage is an international consortium aimed at developing AI algorithms for precision medicine in oncology and enabling secondary use of the data based on necessary ethical approvals. The use of well-defined clinical data standards to allow interoperability was a central element within the initiative. The consortium is focused on three different cancer types and addresses seven unmet clinical needs. This article synthesises our experience and procedures for healthcare data interoperability and standardisation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952103.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis study describes a new process to harmonize and standardize clinical data. The data will be available upon request to the authors.
AB - An unprecedented amount of personal health data, with the potential to revolutionise precision medicine, is generated at healthcare institutions worldwide. The exploitation of such data using artificial intelligence relies on the ability to combine heterogeneous, multicentric, multimodal and multiparametric data, as well as thoughtful representation of knowledge and data availability. Despite these possibilities, significant methodological challenges and ethico-legal constraints still impede the real-world implementation of data models. The EuCanImage is an international consortium aimed at developing AI algorithms for precision medicine in oncology and enabling secondary use of the data based on necessary ethical approvals. The use of well-defined clinical data standards to allow interoperability was a central element within the initiative. The consortium is focused on three different cancer types and addresses seven unmet clinical needs. This article synthesises our experience and procedures for healthcare data interoperability and standardisation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952103.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis study describes a new process to harmonize and standardize clinical data. The data will be available upon request to the authors.
U2 - 10.1101/2024.03.15.24303032
DO - 10.1101/2024.03.15.24303032
M3 - Preprint
T3 - medRxiv
BT - New implementation of data standards for AI research in precision oncology. Experience from EuCanImage
ER -